The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...
If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union.
COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...
Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.
Europe's medicines regulator on Friday recommended granting marketing authorisation to mCombriax, making Moderna's messenger RNA vaccine the world's first combined shot for ...
European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...
While the FDA has flip-flopped on whether to review Moderna’s combination influenza and COVID-19 vaccine, it’s full speed ahead for the mRNA shot in Europe. | While the FDA has flip-flopped on whether ...
With the CHMP affirmation, Moderna is on course to get EU approval for its fourth vaccine product and break new ground in ...
A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, ...
In a recent study published in the medRxiv preprint* server, in response to the COVID-19-associated total death toll reports from 54 European nations, areas, and territories (“CAT”), researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results